N. Kuse

发表

A molecular basis for the control of preimmune escape variants by HIV-specific CD8+ T cells.

Victor Appay, Laurence Meyer, Masafumi Takiguchi, 2013, Immunity.

Existence of Replication-Competent Minor Variants with Different Coreceptor Usage in Plasma from HIV-1-Infected Individuals

S. Matsushita, T. Takemura, T. Yamashiro, 2020, Journal of Virology.

Impact of a single HLA-A*24:02-associated escape mutation on the detrimental effect of HLA-B*35:01 in HIV-1 control

S. Rowland-Jones, S. Oka, M. Koyanagi, 2018, EBioMedicine.

Multilayered Defense in HLA-B51–Associated HIV Viral Control

M. John, S. Rowland-Jones, A. McMichael, 2011, The Journal of Immunology.

Impact of Micropolymorphism Outside the Peptide Binding Groove in the Clinically Relevant Allele HLA-C*14 on T Cell Responses in HIV-1 Infection

P. Borrow, S. Oka, Wayne Paes, 2022, Journal of virology.

Effect of Difference in Consensus Sequence between HIV-1 Subtype A/E and Subtype B Viruses on Elicitation of Gag-Specific CD8+ T Cells and Accumulation of HLA-Associated Escape Mutations

S. Oka, H. Gatanaga, M. Takiguchi, 2020, Journal of Virology.

Critical effect of Pol escape mutations associated with detrimental allele HLA-C∗15:05 on clinical outcome in HIV-1 subtype A/E infection

M. Takiguchi, T. Chikata, N. Kuse, 2020, AIDS.

Accumulation of Pol Mutations Selected by HLA-B*52:01-C*12:02 Protective Haplotype-Restricted Cytotoxic T Lymphocytes Causes Low Plasma Viral Load Due to Low Viral Fitness of Mutant Viruses

S. Oka, M. Koyanagi, H. Gatanaga, 2016, Journal of Virology.

Priming of HIV-1-specific CD8+ T cells with strong functional properties from naïve T cells

V. Appay, M. Takiguchi, N. Kuse, 2019, EBioMedicine.

Long-term memory CD8+ T cells specific for SARS-CoV-2 in individuals who received the BNT162b2 mRNA vaccine

S. Oka, H. Gatanaga, M. Takiguchi, 2022, Nature Communications.

Immunological Control of HIV-1 Disease Progression by Rare Protective HLA Allele

S. Oka, H. Gatanaga, M. Takiguchi, 2022, Journal of virology.

Immunological Control of HIV-1 Disease Progression by Rare Protective HLA Allele

S. Oka, H. Gatanaga, M. Takiguchi, 2022, Journal of virology.

Fibrocytes Differ from Macrophages but Can Be Infected with HIV-1

S. Oka, H. Nasser, K. Strebel, 2015, The Journal of Immunology.

Molecular Basis of a Dominant T Cell Response to an HIV Reverse Transcriptase 8-mer Epitope Presented by the Protective Allele HLA-B*51:01

A. Sewell, S. Oka, P. Rizkallah, 2014, The Journal of Immunology.

8-mer Epitope Presented by the Protective Response to an HIV Reverse Transcriptase Molecular Basis of a Dominant T Cell

A. Sewell, S. Oka, D. Cole, 2014 .

Broad Recognition of Circulating HIV-1 by HIV-1-Specific Cytotoxic T-Lymphocytes with Strong Ability to Suppress HIV-1 Replication

S. Oka, H. Gatanaga, M. Takiguchi, 2018, Journal of Virology.

Adaptation of HIV-1 to human leukocyte antigen class I

David Heckerman, John Frater, Rodney Phillips, 2009, Nature.

A strong association of human leukocyte antigen-associated Pol and Gag mutations with clinical parameters in HIV-1 subtype A/E infection

J. Carlson, S. Oka, Z. Brumme, 2016, AIDS.

Selection of TI8-8V Mutant Associated with Long-Term Control of HIV-1 by Cross-Reactive HLA-B*51:01–Restricted Cytotoxic T Cells

S. Oka, H. Gatanaga, M. Takiguchi, 2014, The Journal of Immunology.

Cross-Reactive HLA-B * 51 : 01 Long-Term Control of HIV-1 by Selection of TI 8-8 V Mutant Associated with

S. Oka, H. Gatanaga, M. Takiguchi, 2014 .

Long-Term Control of HIV-1 in Hemophiliacs Carrying Slow-Progressing Allele HLA-B*5101

P. Goulder, S. Oka, H. Gatanaga, 2010, Journal of Virology.

T-cell responses to sequentially emerging viral escape mutants shape long-term HIV-1 population dynamics

S. Oka, Z. Brumme, C. Brumme, 2020, PLoS pathogens.

HLA Class I-Mediated HIV-1 Control in Vietnamese Infected with HIV-1 Subtype A/E

M. Carrington, Y. Qi, S. Oka, 2017, Journal of Virology.

Effects of a Single Escape Mutation on T Cell and HIV-1 Co-adaptation.

C. Schönbach, G. Gao, V. Appay, 2016, Cell reports.

Distinct HIV-1 Escape Patterns Selected by Cytotoxic T Cells with Identical Epitope Specificity

M. John, S. Mallal, N. Pfeifer, 2012, Journal of Virology.

STING Ligand-Mediated Priming of Functional CD8+ T Cells Specific for HIV-1-Protective Epitopes from Naive T Cells

M. Takiguchi, N. Kuse, T. Akahoshi, 2021, Journal of virology.

HIV-1 Control by NK Cells via Reduced Interaction between KIR2DL2 and HLA-C∗12:02/C∗14:03.

M. Carrington, Y. Qi, S. Oka, 2016, Cell reports.

Collaboration of a Detrimental HLA-B*35:01 Allele with HLA-A*24:02 in Coevolution of HIV-1 with T Cells Leading to Poorer Clinical Outcomes

S. Rowland-Jones, S. Oka, H. Gatanaga, 2021, Journal of virology.

Control of HIV-1 Replication by CD8+ T Cells Specific for Two Novel Pol Protective Epitopes in HIV-1 Subtype A/E Infection

S. Oka, M. Takiguchi, T. Chikata, 2022, Journal of virology.

Superimposed Epitopes Restricted by the Same HLA Molecule Drive Distinct HIV-Specific CD8+ T Cell Repertoires

G. Gao, V. Appay, Yi Shi, 2014, The Journal of Immunology.

T Cell Repertoires + HIV-Specific CD 8 Same HLA Molecule Drive Distinct Superimposed Epitopes Restricted by the Oka and Masafumi

G. Gao, V. Appay, Yi Shi, 2014 .

Role of Escape Mutant-Specific T Cells in Suppression of HIV-1 Replication and Coevolution with HIV-1

S. Oka, H. Gatanaga, M. Takiguchi, 2020, Journal of Virology.

Peptides presented by HLA class I molecules in the human thymus.

F. Canals, R. Pujol-Borrell, M. Carrascal, 2013, Journal of proteomics.

Identification of novel HIV-1-derived HLA-E-binding peptides

A. McMichael, S. Brackenridge, T. Hanke, 2018, Immunology letters.

Effective Suppression of HIV-1 Replication by Cytotoxic T Lymphocytes Specific for Pol Epitopes in Conserved Mosaic Vaccine Immunogens

S. Oka, T. Hanke, H. Gatanaga, 2019, Journal of Virology.

CD8+ T cells specific for conserved, cross-reactive Gag epitopes with strong ability to suppress HIV-1 replication

S. Oka, T. Hanke, H. Gatanaga, 2018, Retrovirology.

Raltegravir and elvitegravir-resistance mutation E92Q affects HLA-B*40:02-restricted HIV-1-specific CTL recognition.

S. Oka, H. Gatanaga, M. Takiguchi, 2014, Microbes and infection.

The STING ligand cGAMP potentiates the efficacy of vaccine-induced CD8+ T cells.

V. Appay, L. Papagno, E. Gostick, 2019, JCI insight.

Different Effects of Nonnucleoside Reverse Transcriptase Inhibitor Resistance Mutations on Cytotoxic T Lymphocyte Recognition between HIV-1 Subtype B and Subtype A/E Infections

S. Oka, M. Koyanagi, H. Gatanaga, 2015, Journal of Virology.

Be Infected with HIV-1 Fibrocytes Differ from Macrophages but Can

S. Oka, H. Nasser, K. Strebel, 2015 .

The TLR9 ligand CpG ODN 2006 is a poor adjuvant for the induction of de novo CD8+ T-cell responses in vitro

V. Appay, L. Papagno, E. Gostick, 2020, Scientific Reports.

The STING ligand cGAMP potentiates the efficacy of vaccine-induced CD8+ T cells.

V. Appay, L. Papagno, E. Gostick, 2019, JCI insight.

A molecular basis for the control of preimmune escape variants by HIV-specific CD8+ T cells.

H. Agut, V. Appay, D. Douek, 2013, Immunity.